Veronica Rodriguez-Bravo
Molecular Biology Program
Memorial Sloan-Kettering Cancer Center
Veronica Rodriguez-Bravo has not added Biography.
If you are Veronica Rodriguez-Bravo and would like to personalize this page please email our Author Liaison for assistance.
Chk1- and claspin-dependent but ATR/ATM- and Rad17-independent DNA replication checkpoint response in HeLa cells.
Cancer research Sep, 2006 | Pubmed ID: 16951182
Different S/M checkpoint responses of tumor and non tumor cell lines to DNA replication inhibition.
Cancer research Dec, 2007 | Pubmed ID: 18089794
The decision to enter mitosis: feedback and redundancy in the mitotic entry network.
The Journal of cell biology Apr, 2009 | Pubmed ID: 19364923
Plk1 self-organization and priming phosphorylation of HsCYK-4 at the spindle midzone regulate the onset of division in human cells.
PLoS biology May, 2009 | Pubmed ID: 19468302
Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.
Cancer cell Sep, 2012 | Pubmed ID: 22975379
Nuclear pores protect genome integrity by assembling a premitotic and mad1-dependent anaphase inhibitor.
Cell Feb, 2014 | Pubmed ID: 24581499
A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer.
Cancer cell Feb, 2015 | Pubmed ID: 25670080
The role of GATA2 in lethal prostate cancer aggressiveness.
Nature reviews. Urology Jan, 2017 | Pubmed ID: 27872477
The PP2A(B56) phosphatase promotes the association of Cdc20 with APC/C in mitosis.
Journal of cell science May, 2017 | Pubmed ID: 28404789
Targeting sarcoma tumor-initiating cells through differentiation therapy.
Stem cell research May, 2017 | Pubmed ID: 28433655
Mps1 Regulates Kinetochore-Microtubule Attachment Stability via the Ska Complex to Ensure Error-Free Chromosome Segregation.
Developmental cell Apr, 2017 | Pubmed ID: 28441529
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import.
Cell 08, 2018 | Pubmed ID: 30100187
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。